Actively Recruiting
Parathyroid Tumor Clonal Status
Led by Washington University School of Medicine · Updated on 2026-05-12
839
Participants Needed
1
Research Sites
444 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To define the frequency of monoclonal-X and polyclonal-X tumors in hyperparathyroid disorders patients having PTX and to define the relationship between parathyroid tumor clonal status and multiple gland neoplasia (MGN), we will compare surgical and pathologic outcomes to tumor clonal status in a multicenter cohort of patients having bilateral neck exploration (BNE) and PTX (primary objectives).
CONDITIONS
Official Title
Parathyroid Tumor Clonal Status
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with hyperparathyroidism (primary, secondary, or tertiary), confirmed by blood tests and undergoing treatment
- Female and male patients
- Age 18 years or older
- Able to understand and willing to sign informed consent
You will not qualify if you...
- History of radiation treatment to the neck or face
- Current or past use of lithium
- Pregnant patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110
Actively Recruiting
Research Team
J
John A Olson, MD
CONTACT
K
Kathleen Harris
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here